THE BIOMEDICAL RESEARCH INSTITUTE OF SOUTHERN CALIFORNIA (EIN 452210161) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2011

Legal Domicile

Principal Officer

SALLY SARAWAR

Phone

8887235830

Tax Period

2023-01-01 to 2023-12-31

THE BIOMEDICAL RESEARCH INSTITUTE OF SOUTHERN CALIFORNIA, founded in 2011, is a small nonprofit in the Medical Research sector that reported $208K in total revenue in fiscal year 2023. Revenue surged 188% from the prior year, signaling strong growth momentum. Expenses of $189K left a modest 9% surplus.

Mission

TO CONDUCT BASIC AND TRANSLATIONAL BIOMEDICAL RESEARCH AIMED AT UNDERSTANDING, PREVENTING OR CURING HUMAN DISEASE.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $178,181

Program Service Revenue $0

Investment Income $0

Other Revenue $30,068

TOTAL REVENUE $208,249

Expense Breakdown

Grants Paid $0

Salaries & Benefits $101,118

Fundraising Expenses $0

Program Expenses $171,971

Other Expenses $87,877

TOTAL EXPENSES $188,995

Year-over-Year Comparison

	2023	2022	Change
Revenue	$208,249	$72,428	+1.9%
Expenses	$188,995	$91,029	+1.1%
Net Income	$19,254	$-18,601	-2.0%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

Volunteers

N/A

Governance Policies

✓ Conflict of Interest Policy

✓ Whistleblower Policy

✓ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

$34,683

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
DR CRAIG JACKSON	CHAIRMAN OF BOARD OF DIREC	0.50	Director	$0	$0	$0
DR LEMAN YEL	DIRECTOR	0.30	Director	$0	$0	$0
DR PETER DIAS	CFO	20.00	Officer Director	$0	$0	$0
MR MICHAEL GISKE	DIRECTOR	0.50	Director	$0	$0	$0
DR SALLY SARAWAR	PRESIDENT AND CEO	20.00	Officer	$34,683	$0	$34,683

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2023	$208,249	$188,995	$60,330	$19,254
2020	$352,753	$352,568	$52,606	$185
2019	$924,036	$923,840	$52,547	$196
2018	$818,213	$818,116	$83,144	$97

THE BIOMEDICAL RESEARCH INSTITUTE OF SOUTHERN CALIFORNIA